Author Question: A drug that would treat obesity might be expected to A) promote the activity of uncoupling ... (Read 36 times)

littleanan · **on:** Jun 22, 2018

A drug that would treat obesity might be expected to

A) promote the activity of uncoupling protein in skeletal muscle.
B) suppress metabolic rate.
C) impair the activity of uncoupling protein in skeletal muscle.
D) promote the development of a thrifty phenotype.
E) block the transport of leptin into the brain.

Question 2

A key factor for the success of the RYGB procedure for the treatment of obesity is that

A) the procedure increases the rate of entry of insulin into the brain.
B) it disrupts the secretion of CCK.
C) it increases the activity of NPY neurons.
D) it disrupts the secretion of ghrelin.
E) it decreases the secretion of leptin from fat cells.

milbourne11 · **Reply #1 on:** Jun 22, 2018

Answer to Question 1

Answer: A
Rationale: A drug that would treat obesity might be expected to promote the activity of uncoupling protein in skeletal muscle.

Answer to Question 2

Answer: D
Rationale: A key factor for the success of the RYGB procedure for the treatment of obesity is that it disrupts the secretion of ghrelin.